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Standards for infant formula milk
Commercial interests may be the strongest driver of what goes into formula milk
The quality of infant feeding is of paramountimportance for growth, development, and longterm health well into adulthood.1 Breast
feeding is recognised as the ideal form of infant
feeding, providing multiple benefits for child health.2
Thus breast feeding should be actively promoted, pro-
tected, and supported. Infants who cannot be fed at the
breast, who should not receive breast milk, or for whom
breast milk is not available need infant formula milks
of high quality.3
The Codex Alimentarius Commission, part of both
the Food and Agriculture Organization of the United
Nations (FAO) and the World Health Organization,
develops standards, guidelines, and related texts on food
to protect consumers’ health and to ensure fair trade
practices globally. Most of the world’s population lives in
the more than 160 countries that are members of the
Codex Alimentarius. Its standard on infant formula was
adopted in 1981, based on scientific knowledge of the
1970s,4 and it is currently being revised.
At the end of November 2005 the Codex Commit-
tee on Nutrition and Foods for Special Dietary Uses
met in Bonn, Germany, and discussed among other
issues revision of the standard on infant formula. The
meeting was attended by government delegations of
some 71 member states of the committee, along with
observers of 32 international non-governmental
organisations, mostly umbrella organisations for food
manufacturers and other groups with commercial
interests in infant formula.
Infant formula must be the sole source of nutrients
for several months during a critical phase of growth
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and development, and thus it must meet very high
quality standards. After several years of work on the
draft standard for infant formula, the committee had
requested from an international group of experts a sci-
ence based review on the compositional requirements
for infant formula to facilitate the process of taking
decisions in this area.5 Two issues arising at the meeting
in Bonn showed, however, that scientific and medical
arguments may be unduly influenced by commercial
considerations.
Three recent scientific reviews on the composi-
tional requirements of infant formula by expert groups
reporting to the Food and Drug Administration (FDA)
in the United States, the European Commission, and
the Codex Alimentarius Commission all agreed that
the determination of infant formula protein should be
based on total nitrogen content multiplied by a
conversion factor of 6.25.5–7 This nitrogen conversion
factor is also used in the new WHO/FAO report on
human protein requirements (currently in prepara-
tion) for calculating both safe levels of protein intake in
infants and human milk protein content, as well as in
the Codex guidelines on nutrition labelling.8
In Bonn, however, the International Dairy Federa-
tion demanded that the proportion of protein in form-
ula derived from cows’ milk should be determined with
a conversion factor of 6.38—as conventionally used for
whole cows’ milk and based on data published in 18839
—even though modern infant formulas contain modi-
fied cows’ milk protein fractions for which this factor is
not appropriate.5–7 Moreover, a conversion factor for
nitrogen in cows’ milk that is higher than that used for
human milk proteins would suggest that cows’ milk has
a greater biological value, which clearly is not the case.
Even though no scientific arguments were put for-
ward to justify the federation’s request, it got support
from several Codex member states with strong dairy
industries. Meanwhile, an internal newsletter of the
German dairy industry association, the Milchindus-
trieverband (www.vdm-deutschland.de), suggested that
the application of a nitrogen conversion factor of 6.25
instead of 6.38 for all dairy products would lead to a
loss of some €80m (£55m; $96m) for the dairy industry
in Europe alone
Another controversial issue was the approach to
setting maximum values for nutrients. Maximum
values have been proposed for most nutrients in infant
formula by all the recent expert consultations in order
to provide safe and nutritionally adequate infant
formula products meeting the normal nutritional
requirements of babies.5–7 The guiding principle is that
infant formulas should contain components only in
such amounts that serve a nutritional purpose, provide
another benefit, or are necessary for technological rea-
sons. The inclusion of unnecessary components, or
unnecessary amounts of components, may put a
burden onmetabolic and other physiological functions
of the infant and will reduce the margin of safety.5
These maximum values should be based on
available scientific data on infants’ requirements and
the absence of adverse effects. For example, maximum
values for vitamin A were based on scientific risk
assessment that took into account the upper safe levels
of intake established for infants and young children.5–7
For some water soluble vitamins acceptable daily
intakes for infants and young children have not been
established. If these vitamins are supplied in amounts
that cannot be used or stored by the body they must be
excreted, and excessive intakes will reduce the margin
of safety. This is particularly the case under conditions
of stress such as during fever or diarrhoea or especially
during weight loss. Therefore, the scientific expert
report to Codex recommended that contents of water
soluble vitamins in infant formulas generally should
not exceed five times the minimum level unless there
are data to justify other decisions.5
Contrary to this strong scientific advice, delega-
tions to the Codex committee from some member
states requested that maximum values should be estab-
lished only for levels of nutrients with documented
adverse effects in infants, while in all other cases only
interim upper values should be established which
would not be binding for manufacturers. Moreover, the
US delegation requested that both maximum values
and guidance values should not be lower than values
used for formulas already on the market, even if such
levels have not been subjected to systematic evaluation
of their biological effects and safety. The underlying
concept that levels of exposure determine safety is
unknown in science, be it in toxicology, pharmacology,
or nutrition. None the less, the committee has agreed
to collect, before its next session in 2006, data on
observed high nutrient levels in infant formula in
different countries.
The worldwide medical community might question
the basis of the decisions of Codex Alimentarius on the
global guidelines for infant formula standards and
might rise to reject such commercial pressures.
Doctors should choose and recommend only those
infant formulas with compositions based on current
scientific knowledge and on the nutritional require-
ments of infants.
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